ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion

May 9, 1997

DePinho Seeks Broad Waiver From COI Policy To Cover Financial Ties With 12 Entities

September 21, 2012

Adding Ultrasound Revealed More Breast Cancers In Study

May 30, 2008

Letter to the Editor

March 21, 2003

Oncology Nursing Foundation Offers Research Fellowship, Clinical Scholar Award

September 29, 1995

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

October 9, 1992